Abstract
The purpose of this study was to determine the outcome of surgery for patients with recurrent gastric or gastroesophageal cancer. We queried records from 7,459 patients who presented with gastric or gastroesophageal cancer to our institution from 1973 through 2005 to identify those for whom resection of recurrent disease had been attempted. We assessed the associations between various clinicopathologic factors and resectability with logistic regression analysis and between clinicopathologic factors and overall survival (OS) with the Cox proportional hazards model. Sixty patients underwent attempted resection for recurrent cancer. In 31 cases (52%), recurrent disease proved unresectable at laparotomy. Factors associated with the ability to undergo re-resection included neoadjuvant treatment prior to initial resection [odds ratio (OR) 12.2, 95% confidence interval (CI) 1.9–75.6] and having an isolated local recurrence (OR 5.1, 95% CI 1.3–20.5). Of the 29 patients who underwent re-resection, 14 required adjacent organ resection, and 6 required interposition grafting. Three- and 5-year OS rates for all 60 patients were 21% and 12%, respectively; median follow-up time was 23 months. Median OS for patients undergoing resection was 25.8 months (95% CI 17.1–49.8) versus 6.0 months (95% CI 4.0–10.5) for unresectable patients (P < 0.001). Initial tumor location at the gastroesophageal junction was associated with diminished OS [hazard ratio (HR) 2.8, 95% CI 1.2–6.5] and ability to undergo resection of recurrence was associated with improved OS (HR 0.2, 95% CI 0.1–0.6). We conclude that surgical resection of select patients with recurrent gastric or gastroesophageal cancer can result in improved OS but often requires adjacent organ resection or interposition graft placement.
Similar content being viewed by others
References
Maehara Y, Hasuda S, Koga T, et al. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg. 2000;87:353–7.
Schwarz RE, Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol. 2002;9:394–400.
D’Angelica M, Gonen M, Brennan MF, et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808–16.
Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236–42.
Kodera Y, Ito S, Yamamura Y, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol. 2003;10:898–902.
Carboni F, Lepiane P, Santoro R, et al. Treatment for isolated locoregional recurrence of gastric adenocarcinoma: does surgery play a role? World J Gastroenterol. 2005;11:7014–7.
Miller RC, Haddock MG, Gunderson LL, et al. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas. Dis Esophagus. 2006;19:487–95.
Bohner H, Zimmer T, Hopfenmuller W, et al. Detection and prognosis of recurrent gastric cancer –is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology. 2000;47:1489–94.
Takeyoshi I, Ohwada S, Ogawa T, et al. The resection of nonhepatic intraabdominal recurrence of gastric cancer. Hepatogastroenterology. 2000;47:1479–81.
Inada T, Ogata Y, Andoh J, et al. Significance of paraaortic lymph node dissection in patients with advanced and recurrent gastric cancer. Anticancer Res. 1994;14:677–82.
Shchepotin I, Evans SR, Shabahang M, et al. Radical treatment of locally recurrent gastric cancer. Am Surg. 1995;61:371–6.
Huguier M, Houry S, Lacaine F. Is the follow-up of patients operated on for gastric carcinoma of benefit to the patient? Hepatogastroenterology. 1992;39:14–6.
Makela J, Kairaluoma MI. Rationale of reoperation for gastric malignancies. Ann Chir Gynaecol. 1985;74:77–81.
Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Spring-Verlag; 2002.
Snedecor G, Cochran, WG. Statistical methods. Ames: Iowa State University Press; 1980.
Kaplan E, Meier, P. Nonparametric estimator from incomplete observations. J Am Stat Assoc. 1958;53:457–81.
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;60:163–70.
Adachi Y, Kitano S, Sugimachi K. Surgery for gastric cancer: 10-year experience worldwide. Gastric Cancer. 2001;4:166–74.
Davis PA, Sano T. The difference in gastric cancer between Japan, USA, and Europe: what are the facts? what are the suggestions? Crit Rev Oncol Hematol. 2001;40:77–94.
Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol. 2006;24:2188–96.
An JY, Youn HG, Ha TK, et al. Clinical significance of tumor location in remnant gastric cancers developed after partial gastrectomy for primary gastric cancer. J Gastrointest Surg. 2008;12(4):689–94.
Ohashi M, Katai H, Fukagawa T, et al. Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg. 2007;94:92–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Badgwell, B., Cormier, J.N., Xing, Y. et al. Attempted Salvage Resection for Recurrent Gastric or Gastroesophageal Cancer. Ann Surg Oncol 16, 42–50 (2009). https://doi.org/10.1245/s10434-008-0210-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-008-0210-x